Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
Lorena P. Suarez-Kelly,Steven H. Sun,Casey Ren,Isaac V. Rampersaud,David Albertson,Megan C. Duggan,Tiffany C. Noel,Nicholas Courtney,Nathaniel J. Buteyn,Charles Moritz,Lianbo Yu,Vedat O. Yildiz,Jonathan P. Butchar,Susheela Tridandapani,Arfaan A. Rampersaud,William E. Carson
DOI: https://doi.org/10.1021/acsanm.1c00256
IF: 6.14
2021-03-11
ACS Applied Nano Materials
Abstract:Background: fluorescent nanodiamonds (FND) are nontoxic, infinitely photostable nanoparticles that emit near-infrared fluorescence and have a modifiable surface allowing for the generation of protein–FND conjugates. FND-mediated immune cell targeting may serve as a strategy to visualize immune cells and promote immune cell activation. Methods: uncoated-FND (uFND) were fabricated, coated with glycidol (gFND), and conjugated with immunoglobulin G (IgG–gFND). <i>In vitro</i> studies were performed using a breast cancer/natural killer/monocyte co-culture system, and <i>in vivo</i> studies were performed using a breast cancer mouse model. Results: <i>in vitro</i> studies demonstrated the targeted immune cell uptake of IgG–gFND, resulting in significant immune cell activation and no compromise in immune cell viability. IgG–gFND remained at the tumor site following intratumoral injection compared to uFND which migrated to the liver and kidneys. Conclusion: antibody-conjugated FND may serve as immune drug delivery vehicles with "track and trace capabilities" to promote directed antitumor activity and minimize systemic toxicities.This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology